查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2016042

即时分子诊断市场报告：按产品/服务、技术、应用、最终用户和地区划分（2026-2034 年）

Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2025年，全球即时分子诊断市场规模达44亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到90亿美元，2026年至2034年的复合年增长率（CAGR）为8.09%。北美地区凭藉其完善的医疗基础设施、强大的行业领导者以及创新诊断技术的高普及率，正引领市场成长。感染疾病率的上升和医疗设施的快速发展也显着推动了市场成长。

即时分子诊断（POC）是指医师为诊断和检测感染疾病而进行的检测。这些检测包括血液学检测、怀孕检测、不孕症检测、感染疾病、尿液检查以及心臟代谢和血糖监测设备。 POC分子诊断广泛用于病原体鑑定、微量残存疾病（MRD）和胃肠道疾病的诊断、血红蛋白和粪便潜血的监测，以及确定患者对特定药物或药物类别的代谢能力。这些检测能够更快获得结果，减少误诊併发症，并改善感染控制。因此，POC分子诊断广泛应用于医院、加护病房（ICU）、实验室、诊所、分散式检查和居家医疗机构。

即时分子诊断市场趋势：

慢性病和感染疾病率上升

癌症、糖尿病、心血管疾病和感染疾病爆发等疾病的盛行率不断上升，凸显了快速、精准诊断技术的必要性。即时分子诊断具有快速识别的优势，能够实现及时的医疗干预和高效的疾病管理。这对于延缓疾病进展、提高患者存活率和控制感染疾病传播尤为重要。此外，即时分子诊断能够追踪疾病进展和治疗效果，进而改善整体医疗保健管理。随着人口老化和不断变化的健康风险增加，医疗保健系统对诊断服务的需求也随之增长，即时分子诊断提供了一种扩充性且有效的解决方案。持续应对复杂健康问题的需求正在推动其应用，而疾病盛行率的上升则是市场成长的主要驱动力。

人口老化的过程

老年人罹患慢性病、感染疾病和老龄化相关疾病的风险更高，因此快速且准确的诊断对于有效治疗至关重要。随着医疗卫生系统为应对日益增长的需求做好准备，快速、准确且易于获取的诊断工具对于促进早期发现和介入至关重要。世界卫生组织（世卫组织）指出，到2030年，全球六分之一的人口将超过60岁，预计2050年，数字将达到21亿。此外，80岁及以上人口的数量预计将增加两倍，到2050年达到4.26亿。这种人口结构的变化预计将给医疗卫生系统带来沉重负担，凸显了对尖端即时分子诊断技术的迫切需求，以改善患者预后、减轻医院负担并促进高效分散的医疗服务。

分散式医疗服务的重要性

随着医疗保健需求的增长，尤其是在农村、偏远和资源匮乏地区，无需依赖集中式检测机构即可提供快速、准确、可靠结果的诊断工具变得日益重要。即时分子诊断透过提供快速的现场检测方案，有效应对了这项挑战，显着减少了检体运输延误、储存问题以及集中处理造成的延误等物流障碍。这种分散化确保患者能够更早获得介入措施和更精准的治疗方案，从而改善医疗保健效果并减轻疾病负担。此外，随着对成本控制和营运效率的日益重视，医疗机构正在利用这些技术来改善病患管理、提高工作流程效率并最大限度地利用现有资源。分散式医疗服务透过提高医疗服务的可近性、加快检测速度和最大限度地减少系统性低效，持续成长要素。

即时分子诊断市场成长要素：

对价格合理且准确的诊断解决方案的需求

随着医疗系统努力确保可靠检测的广泛普及，经济实惠的分子诊断平台的重要性日益凸显。这些解决方案兼具高精度和低营运成本，使得诊所、药局甚至家庭环境都能更方便地进行检测。经济实惠的诊断技术简化了工作流程，无需复杂的样本製备，也减少了对专业培训的需求，从而缩短了结果报告时间。这种兼顾准确度和成本效益的优势将逐步取代可靠性较低的检测方法，最终改善患者预后，并提升疾病管理水准。随着医疗系统日益重视以价值为导向的医疗服务，对经济高效且精准的诊断的需求成为市场成长的关键驱动力。 2024年，3EO Health在美国推出了一款无需CLIA照护现场分子诊断平台，提供价格低于20美元的COVID-19检测，且无需检体製备。这款紧凑型3TR系统可在诊所和家庭环境中实现经济高效的检测，旨在以具有分子级精准度的检测方法取代抗原检测。

携带式诊断技术的进步

与传统实验室相比，紧凑易用的设备能够实现更可靠的检测，从而扩大都市区地区获得关键诊断服务的途径。这些进步能够提供快速且准确的检测结果，支援快速的临床决策，并最大限度地减少集中检测中心的等待时间。便携性的提升使医护人员能够在各种场所进行检测，从社区医疗机构到偏远诊所，从而扩大医疗服务的覆盖范围，并改善疾病控制效果。易于部署和低基础设施要求使得携带式诊断设备用途广泛。携带式分子诊断技术的创新提高了效率、扩充性和可及性，推动了市场对全球医疗服务进步的贡献，并确保了关键检测的公平获取。 2024年，Molbio在印度提供的照护现场分子诊断平台Truenat因其在结核病控制方面发挥的作用，在第77届世界卫生大会上奖励。这款携带式电池供电的PCR设备可在1小时内提供快速、高度准确的检测结果，并在印度广泛部署。

与数位健康和​​数据分析的整合

照护现场分子诊断、数位健康平台和先进数据分析的结合正在推动市场成长。云端资料储存、行动医疗健康应用和电子健康记录 (EHR) 整合等现代连接功能，实现了在整个医疗保健网路中无缝传输、存取和监测诊断结果。这种互通性使医疗专业人员能够存取即时数据、监测疾病进展并有效率地制定个人化治疗方案，从而增强临床决策能力。此外，分析洞察透过识别疾病趋势、预测潜在疫情爆发和优化医疗资源分配，为人群健康管理提供支援。将诊断技术与远端医疗服务和远距监测系统结合，还能使农村和医疗资源匮乏地区的患者获得快速、准确和持续的医疗服务。这个整合生态系统有助于提高诊断准确性和营运效率，增强患者参与度和治疗依从性，从而推动即时分子诊断在全球范围内的普及应用。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球即时分子诊断市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品及服务划分

  • 检测和试剂盒
  • 仪器和分析设备
  • 软体和服务

第七章 市场区隔：依技术划分

  • 聚合酵素链锁反应（PCR）
  • 杂合反应
  • DNA定序
  • 微阵列
  • 恒温核酸增幅技术（INAAT）
  • 其他的

第八章 市场区隔：依应用领域划分

  • 感染疾病
  • 肿瘤学
  • 血液学
  • 产前检查
  • 内分泌学
  • 其他的

第九章 市场区隔：依最终用户划分

  • 诊所
  • 医院及重症监护室
  • 研究机构
  • 其他的

第十章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十一章 SWOT 分析

第十二章：价值链分析

第十三章：波特五力分析

第十四章：价格分析

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • binx health, inc.
    • Cepheid（Danaher Corporation）
    • Co-Diagnostics Inc.
    • F. Hoffmann-La Roche Ltd
    • Meridian Bioscience
    • Molbio Diagnostics Limited
    • QuantuMDx Group Limited
    • Thermo Fisher Scientific Inc.
    • Visby Medical Inc.
Product Code: SR112026A6271

The global point of care molecular diagnostics market size reached USD 4.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.09% during 2026-2034. North America dominates the market owing to its improved healthcare infrastructure, strong presence of key industry players, and high adoption of innovative diagnostic technologies. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth.

Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.

POINT OF CARE MOLECULAR DIAGNOSTICS MARKET TRENDS:

Rising Prevalence of Chronic and Infectious Diseases

The rising prevalence of diseases like cancer, diabetes, cardiovascular issues, and infectious outbreaks underscores the need for swift and precise diagnostic techniques. Point-of-care molecular diagnostics offer the benefit of prompt identification, allowing for timely medical action and efficient disease management. This is especially crucial for slowing disease progression, enhancing patient survival rates, and limiting the transmission of infectious diseases. In addition, the capability of point of care molecular diagnostics to track disease advancement and treatment efficacy enhances overall care management. With healthcare systems experiencing increased demand for diagnostic services from aging populations and changing health risks, point of care molecular diagnostics offer a scalable and effective solution. The ongoing necessity to tackle intricate health issues reinforces their acceptance, positioning disease prevalence as a key factor impelling the market growth.

Growing Geriatric Population

Elderly people are at greater risk for chronic illnesses, infectious diseases, and age-associated conditions, necessitating prompt and accurate diagnostics for effective treatment. As healthcare systems gear up to handle these increasing demands, the necessity for swift, precise, and readily available diagnostic tools is essential to facilitate early detection and intervention. The World Health Organization (WHO) emphasizes that by 2030, one in six people globally will be 60 years or older, and this figure is expected to reach 2.1 billion by 2050. Furthermore, the number of individuals aged 80 and over is predicted to grow three times, totaling 426 million by 2050. This demographic change is expected to exert significant strain on healthcare systems, highlighting the need for cutting-edge point-of-care molecular diagnostics to improve patient results, lessen hospital pressures, and facilitate effective, decentralized healthcare provision.

Emphasis on Decentralized Healthcare Delivery

With the growing healthcare needs, especially in rural, isolated, and resource-constrained areas, the need for diagnostic tools that can provide quick, accurate, and dependable results without relying on centralized lab facilities is becoming more vital. Point of care molecular diagnostics effectively tackle this issue by offering quick, on-site testing options that greatly minimize logistical obstacles like delays from sample transport, storage problems, and centralized processing delays. This decentralization guarantees that patients access earlier interventions and more precise treatment paths, leading to enhanced healthcare results and lower disease burdens. Additionally, as the focus on cost control and operational effectiveness grows, healthcare organizations are utilizing these technologies to improve patient management, boost workflow efficiency, and make the most of existing resources. Decentralized healthcare delivery remains a key growth factor for the point-of-care molecular diagnostics market by enhancing accessibility, speeding up turnaround times, and minimizing systemic inefficiencies.

POINT OF CARE MOLECULAR DIAGNOSTICS MARKET GROWTH DRIVERS:

Demand for Affordable and Accurate Diagnostic Solutions

As healthcare systems strive to ensure broad access to dependable testing, affordable molecular platforms are gaining significance. These solutions merge high precision with lower operational costs, enabling wider accessibility in clinics, pharmacies, and even home environments. Affordable diagnostic technologies simplify workflows and decrease turnaround times by removing intricate sample preparation and lessening the requirement for specialized training. This equilibrium between accuracy and cost-effectiveness facilitates the substitution of unreliable testing techniques, leading to enhanced patient results and superior disease management. As healthcare systems focus on value-based care, the need for cost-effective and precise diagnostics is a vital factor propelling the market growth. In 2024, 3EO Health launched its CLIA-waived point-of-care molecular diagnostics platform in the US, offering COVID-19 testing under $20 with no sample prep. The compact 3TR system enabled affordable, high-efficiency testing in clinics and homes, aiming to replace antigen tests with molecular accuracy.

Advancements in Portable Diagnostic Technologies

Small and easy-to-use devices are facilitating dependable testing beyond conventional lab environments, broadening access to essential diagnostic services in urban and rural regions. These advancements deliver quick, precise outcomes, aiding prompt clinical choices and minimizing the wait times linked to centralized testing centers. Improved portability enables healthcare professionals to perform testing in various settings, ranging from community health facilities to distant clinics, thus expanding healthcare access and enhancing disease management results. The simplicity of deployment, paired with low infrastructure needs, enables portable diagnostics to be highly versatile for extensive usage. Enhancing efficiency, scalability, and accessibility, innovations in portable molecular diagnostics bolster the market's contribution to advancing global healthcare delivery and guaranteeing fair access to vital testing. In 2024, India's Truenat, a point-of-care molecular diagnostics platform by Molbio, was recognized at the 77th World Health Assembly for its role in combating TB. The portable, battery-operated PCR device delivers rapid, high-accuracy results in under an hour and is widely deployed across India.

Integration with Digital Health and Data Analytics

The combination of point-of-care molecular diagnostics with digital health platforms and sophisticated data analytics is contributing to the market growth. Contemporary connectivity capabilities, such as cloud data storage, mobile health apps, and electronic health record (EHR) integration, enable the smooth transfer, access, and monitoring of diagnostic results throughout healthcare networks. This interoperability enhances clinical decision-making by enabling healthcare providers to obtain real-time data, monitor disease progression, and more efficiently coordinate personalized treatment plans. Additionally, analytics-driven insights support population health management by identifying disease trends, predicting potential outbreaks, and improving the allocation of healthcare resources. Furthermore, integrating diagnostic technologies with telemedicine services and remote monitoring systems allows patients in rural and underserved regions to access prompt, precise, and ongoing care. This cohesive ecosystem promotes enhanced precision and operational effectiveness, alongside increased patient involvement and adherence, supporting the adoption of point-of-care molecular diagnostics globally.

KEY MARKET SEGMENTATION:

Breakup by Product and Service:

  • Assays and Kits
  • Instruments and Analyzers
  • Software and Services

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • Hybridization
  • DNA sequencing
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

Breakup by Application:

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Others

Breakup by End User:

  • Physicians' Offices
  • Hospitals and ICUs
  • Research Institutes
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global point of care molecular diagnostics market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • binx health, inc.
  • Cepheid (Danaher Corporation)
  • Co-Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd
  • Meridian Bioscience
  • Molbio Diagnostics Limited
  • QuantuMDx Group Limited
  • Thermo Fisher Scientific Inc.
  • Visby Medical Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global point of care molecular diagnostics market in 2025?

2. What is the expected growth rate of the global point of care molecular diagnostics market during 2026-2034?

3. What are the key factors driving the global point of care molecular diagnostics market?

4. What has been the impact of COVID-19 on the global point of care molecular diagnostics market?

5. What is the breakup of the global point of care molecular diagnostics market based on the product and service?

6. What is the breakup of the global point of care molecular diagnostics market based on the technology?

7. What is the breakup of the global point of care molecular diagnostics market based on application?

8. What are the key regions in the global point of care molecular diagnostics market?

9. Who are the key players/companies in the global point of care molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point of Care Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Assays and kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments and Analyzers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prenatal Testing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Endocrinology
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Physicians' Offices
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and ICUs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton, Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 binx health, inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Cepheid (Danaher Corporation)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Co-Diagnostics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 F. Hoffmann-La Roche Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Meridian Bioscience
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Molbio Diagnostics Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 QuantuMDx Group Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Visby Medical Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2025
  • Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
  • Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million USD), 2026-2034
  • Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players